141 related articles for article (PubMed ID: 26305023)
1. Prognostic Impact of Visceral Fat Amount and Branched-Chain Amino Acids (BCAA) in Hepatocellular Carcinoma.
Higashi T; Hayashi H; Kaida T; Arima K; Takeyama H; Taki K; Izumi D; Tokunaga R; Kosumi K; Nakagawa S; Okabe H; Imai K; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1041-7. PubMed ID: 26305023
[TBL] [Abstract][Full Text] [Related]
2. Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma.
Itoh S; Shirabe K; Matsumoto Y; Yoshiya S; Muto J; Harimoto N; Yamashita Y; Ikegami T; Yoshizumi T; Nishie A; Maehara Y
Ann Surg Oncol; 2014 Sep; 21(9):3063-8. PubMed ID: 24719020
[TBL] [Abstract][Full Text] [Related]
3. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Abdominal Fat Distribution on Prognosis After Esophagectomy for Esophageal Squamous Cell Carcinoma.
Okamura A; Watanabe M; Mine S; Nishida K; Imamura Y; Kurogochi T; Kitagawa Y; Sano T
Ann Surg Oncol; 2016 Apr; 23(4):1387-94. PubMed ID: 26668084
[TBL] [Abstract][Full Text] [Related]
5. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
[TBL] [Abstract][Full Text] [Related]
6. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
8. Impact of Branched-Chain Amino Acid-Enriched Nutrient on liver Cirrhosis with Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization in Barcelona Clinic Liver Cancer Stage B: A Prospective Study.
Shiozawa S; Usui T; Kuhara K; Tsuchiya A; Miyauchi T; Kono T; Asaka S; Yamaguchi K; Yokomizo H; Shimakawa T; Yoshimatsu K; Katsube T; Naritaka Y
J Nippon Med Sch; 2016; 83(6):248-256. PubMed ID: 28133005
[TBL] [Abstract][Full Text] [Related]
9. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy.
Imai K; Beppu T; Yamao T; Okabe H; Hayashi H; Nitta H; Hashimoto D; Mima K; Nakagawa S; Sakamoto K; Chikamoto A; Ishiko T; Baba H
Ann Surg Oncol; 2014 Nov; 21(12):3817-26. PubMed ID: 24841354
[TBL] [Abstract][Full Text] [Related]
11. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
[TBL] [Abstract][Full Text] [Related]
12. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Kanekawa T; Nagai H; Kanayama M; Sumino Y
Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
[TBL] [Abstract][Full Text] [Related]
13. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
[TBL] [Abstract][Full Text] [Related]
14. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.
Boulet MM; Chevrier G; Grenier-Larouche T; Pelletier M; Nadeau M; Scarpa J; Prehn C; Marette A; Adamski J; Tchernof A
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E736-46. PubMed ID: 26306599
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis.
Nishikawa H; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
Int J Oncol; 2014 Sep; 45(3):1082-90. PubMed ID: 24969042
[TBL] [Abstract][Full Text] [Related]
16. Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios.
Tada T; Kumada T; Toyoda H; Yasuda S; Koyabu T; Nakashima M
Nutr Cancer; 2019; 71(7):1132-1141. PubMed ID: 30955354
[TBL] [Abstract][Full Text] [Related]
17. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
[TBL] [Abstract][Full Text] [Related]
18. Direct effect of branched-chain amino acids on the growth and metabolism of cultured human hepatocellular carcinoma cells.
Sugiyama K; Yu L; Nagasue N
Nutr Cancer; 1998; 31(1):62-8. PubMed ID: 9682250
[TBL] [Abstract][Full Text] [Related]
19. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
Guiu B; Petit JM; Bonnetain F; Ladoire S; Guiu S; Cercueil JP; Krausé D; Hillon P; Borg C; Chauffert B; Ghiringhelli F
Gut; 2010 Mar; 59(3):341-7. PubMed ID: 19837679
[TBL] [Abstract][Full Text] [Related]
20. Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
Miuma S; Ichikawa T; Arima K; Takeshita S; Muraoka T; Matsuzaki T; Ootani M; Shibata H; Akiyama M; Ozawa E; Miyaaki H; Taura N; Takeshima F; Nakao K
J Cell Biochem; 2012 Oct; 113(10):3113-21. PubMed ID: 22581719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
